Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Fenfluramine, tradename Fintepla(®), was appraised within the National Institute for Health and Care Excellence (NICE) single technology appraisal (STA) process as Technology Appraisal 808. Within the STA process, the company (Zogenix International) provided NICE with a written submission and a math...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijnen, Ben, Witlox, Willem, Wolff, Robert, Fayter, Debra, Ramaekers, Bram, Otten, Thomas, Ryder, Steve, Posadzki, Pawel, Worthy, Gill, Stirk, Lisa, Armstrong, Nigel, Kleijnen, Jos, Joore, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813053/
https://www.ncbi.nlm.nih.gov/pubmed/36301414
http://dx.doi.org/10.1007/s40273-022-01209-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813053/
https://www.ncbi.nlm.nih.gov/pubmed/36301414
http://dx.doi.org/10.1007/s40273-022-01209-8

Ejemplares similares